Quantum Blue® TDM

Quantum Blue® TDM

BÜHLMANN Quantum Blue®Infliximab and Quantum Blue®Adalimumab is for Research Use Only in the US. Not for use in diagnostic procedures.BÜHLMANN Quantum Blue®Infliximab: Health Canada License: 98838

Quantum Blue®Adalimumab

The Quantum Blue®Adalimumab assay measures from 1.3 to 35 µg/ml, and the target concentrations lies well within the linear range of the test. Quantum Blue® Adalimumab is unique in the diagnostics market, being the first test that can provide fast, reliable information for adalimumab and it correlates well with the standard routine ELISAs for adalimumab level determinations.

Quantum Blue® Infliximab

The Quantum Blue® Infliximab assay measures from 0.4 to 20 µg/ml, and the target concentrations lies well within the linear range of the test. Quantum Blue® Infliximab provides a quantitative result within 15 minutes of incubation time. Quantum Blue® Infliximab is unique, being the only test that can provide fast, reliable information for infliximab, and correlating well with the standard routine ELISAs for determination of infliximab levels.